Last week Vice President Kamala Harris announced that if elected as president, she would crack down on “abusive practices by pharmaceutical middlemen who squeeze small pharmacies’ profits and raise costs for consumers.”
In a statement from NCPA, CEO Douglas Hoey said, “We are very pleased that Vice President Harris is focused on the predatory, anticompetitive companies that are driving up the cost of prescription drugs, driving small, independent pharmacies out of business, and restricting health care access for millions of patients.”
Hoey also called on former President Donald Trump to also pledge to reform the PBMs. “This is an overwhelmingly bipartisan issue in Congress, and it would be good for the country to see that the two major candidates for president can share this priority despite their other disagreements,” he said. Read the statement here.
